ad

Innova Captab Ltd. (INNOVACAP) 52 Week High Streak: Second Straight Session Near 1-Year Peak

22 Sept 20269:21 am

Innova Captab Ltd. (INNOVACAP) 52 Week High Streak: Second Straight Session Near 1-Year Peak
Innova Captab Ltd. (INNOVACAP) share price is trading within 2% of its 52-week high of Rs 1,239.95 today and later stood at Rs 1,234.7, up 3.11% from the previous close. Market cap was Rs 6,756.83 crore.

Innova Captab Ltd. (INNOVACAP) has now traded within 2% of its 52-week high for its second straight session, with the stock up 4.57% across the streak and last traded at Rs 1234.7. The latest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the move.

As of 22 September 2026 at 9:18 AM IST, the stock was above the previous close of Rs 1197.45 after opening at Rs 1201.25 and touching a low of Rs 1201.25. Turnover stood at Rs 0.05 Cr and market capitalisation at Rs 6756.83 Cr. For readers, the repeated-high pattern matters because it shows persistence across sessions, not just a one-day spike.

Innova Captab Ltd. 52 Week High Streak: Consecutive High Analysis

Metric Value
Current Price Rs 1,234.7
Previous Close Rs 1,197.45
Today's Move +Rs 37.25 (+3.11%)
Open Rs 1,201.25
High Rs 1,239.95
Low Rs 1,201.25
Turnover Rs 0.05 crore
Market Capitalisation Rs 6,756.83 crore

Innova Captab Ltd. (INNOVACAP) traded at Rs 1,234.7 versus the previous close of Rs 1,197.45, a rise of 3.11%. The stock opened at Rs 1,201.25, reached a high of Rs 1,239.95 and touched a low of Rs 1,201.25.

Innova Captab Ltd. Share Price Today shows a rise of Rs 37.25, or 3.11%, versus the previous close, with the stock last traded at Rs 1234.7. The day began at Rs 1201.25 and the low matched that opening level, while the high touched Rs 1239.95. That places the stock near the top of the day’s range, though it is still trading below the intraday peak.

For investors tracking Innova Captab Ltd. Stock News and Innova Captab Ltd. Share Price Update, the key point is that the move is not limited to a single print. The stock has stayed within 2% of its 52-week high for two consecutive sessions, which is why this Innova Captab Ltd. 52 Week High Streak is drawing attention. Turnover remained modest at Rs 0.05 Cr, while market capitalisation at Rs 6756.83 Cr keeps the company in focus in the Healthcare space. The latest trade also keeps Innova Captab Ltd. NSE and BSE watchers alert to whether the pattern persists.

What the Repeated 52-Week Highs Show

Innova Captab Ltd. 52 Week High Streak now reflects a second straight session near the one-year peak, which means the stock has stayed in the same upper price zone across more than one trading day. The cumulative move across the streak is 4.57%, and that is the most useful number for this pattern because it captures the full follow-through rather than one session alone.

The other important data point is the gap between the current 52-week high and the previous one. The latest figures do not include a previous 52-week high value, so that comparison cannot be quantified here. Even so, the streak itself is meaningful for readers searching for Innova Captab Ltd. Consecutive 52 Week High or Innova Captab Ltd. Back To Back 52 Week Highs. It confirms repeated trading near the yearly high, but it does not explain why the move has persisted.

Innova Captab Ltd. (INNOVACAP) Fundamental Analysis

Metric Value
Market Capitalisation Rs 6,756.83 crore
P/E Ratio 43.84x
P/B Ratio 6.04x
ROE 13.75%
ROCE 15.04%
EPS Rs 27.31
Book Value Per Share Rs 198.33
Dividend Yield 0.17%

Innova Captab Ltd. (INNOVACAP) fundamental metrics show P/E 43.84x, P/B 6.04x, ROE 13.75%, ROCE 15.04%. These figures provide context only and are not a buy or sell signal.

Innova Captab Ltd. has a market capitalisation of Rs 6756.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.84x, P/B at 6.04x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.75% and ROCE of 15.04%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 27.31, book value per share of Rs 198.33, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.52x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 43.84x
Benchmark Median P/E 28.52x
Benchmark Average P/E 41.83x
Benchmark P/E Range 0x to 747.32x
Company P/B Ratio 6.04x
Benchmark Median P/B 2.96x
Company ROE 13.75%
Benchmark Median ROE 11.7%
Company ROCE 15.04%
Benchmark Median ROCE 13.61%
Company Market Capitalisation Rs 6,756.83 crore
Benchmark Median Market Cap Rs 729.99 crore

Innova Captab Ltd. (INNOVACAP) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Innova Captab Ltd. (INNOVACAP) has a P/E ratio of 43.84x, which is above the benchmark median of 28.52x, a difference of +53.72%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Innova Captab Ltd. (INNOVACAP) has a ROE of 13.75%, which is above the benchmark median of 11.7%, a difference of +17.52%. Innova Captab Ltd. (INNOVACAP) has a ROCE of 15.04%, which is above the benchmark median of 13.61%, a difference of +10.51%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Morepen Laboratories Ltd. MOREPENLAB 6,624.76 47.71 5.15 7.96 10.19
SYMBIOTEC PHARMALAB LTD SYMBIOTEC 7,024.8 67.73 5.01 11.22 12.41
SENORES PHARMACEUTICALS L SENORES 6,474.21 50.69 6.65 14.14 15.66
Sanofi India Ltd. SANOFI 7,111.86 21.89 8.58 44.5 55.46
Bliss GVS Pharma Ltd. BLISSGVS 7,234.73 51.34 5.67 12.11 17.4

Innova Captab Ltd. (INNOVACAP) has a P/E ratio of 43.84x compared with the displayed peer median of 50.69x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.75% compares with a peer median of 12.11% across the companies shown in the table. ROCE stood at 15.04% versus the displayed peer median of 15.66%, providing a capital-efficiency comparison. Innova Captab Ltd. (INNOVACAP) has a market capitalisation of Rs 6,756.83 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Innova Captab Ltd.

  • Innova Captab Ltd. has traded within 2% of its 52-week high for a second straight session.
  • The cumulative move across the streak is 4.57%, which is the key multi-session measure.
  • The stock last traded at Rs 1234.7, above the previous close of Rs 1197.45.
  • Valuation remains above the industry median on both P/E and P/B.
  • ROE and ROCE are both above the peer-group medians in Healthcare.

About Innova Captab Ltd.

Innova Captab Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s latest market capitalisation stands at Rs 6756.83 Cr, placing it among actively tracked mid-sized names in the listed pharma space. Its financial ratios include a P/E of 43.84, P/B of 6.04, ROE of 13.75% and ROCE of 15.04%.

For readers tracking Innova Captab Ltd. Share Price Today and wider Stock News, the company’s position near its 52-week peak brings both valuation and operating metrics into view. The latest figures also show EPS of Rs 27.31, book value of Rs 198.33 and dividend yield of 0.17%, which provide a basic snapshot for company-level comparison.

Track Innova Captab Ltd. on Univest

Follow Innova Captab Ltd. 52 Week High Streak updates on Univest to monitor how long the stock stays near its one-year high and how the streak develops through the trading day. You can also track Innova Captab Ltd. Share Price Update, Market Cap and related company news on the stock page linked from Univest.

For investors scanning Stocks In News Today or Stocks Hitting 52 Week Highs, this page helps keep the near-peak pattern and the latest company metrics in one place.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why is Innova Captab Ltd. in the news today?

Ans. Innova Captab Ltd. is in focus because it has traded within 2% of its 52-week high for a second straight session. The latest move keeps the stock on the Stocks In News Today list for readers tracking repeated near-high patterns.

How many sessions has Innova Captab Ltd. traded near its 52-week high?

Ans. According to the latest Univest figures, Innova Captab Ltd. has traded within 2% of its 52-week high for two consecutive sessions. That is why this story is framed as an Innova Captab Ltd. 52 Week High Streak.

What is the cumulative move in the streak?

Ans. The stock has gained 4.57% across the streak. This cumulative figure is more informative than the single-day change because it captures the full multi-session run near the one-year high.

Did the data confirm a company-specific catalyst?

Ans. No company-specific catalyst is confirmed in the latest figures. The price pattern is clear, but the numbers only show the streak itself and do not identify a news trigger behind it.

How does Innova Captab Ltd. compare with peers on valuation?

Ans. Innova Captab Ltd. trades above the industry median on both P/E and P/B. and Sanofi India Ltd., but below others such as SYMBIOTEC PHARMALAB LTD.

What are the key fundamental metrics to note?

Ans. The main fundamentals highlighted here are P/E of 43.84, P/B of 6.04, ROE of 13.75%, ROCE of 15.04%, EPS of Rs 27.31 and book value of Rs 198.33. These provide the basic valuation and profitability snapshot.

What does the sector context show?

Ans. Healthcare and Pharmaceuticals & Drugs show a wide spread in valuations and profitability. Innova Captab Ltd. sits above the peer median on returns and valuation, so the sector context matters when comparing it with similar companies.

What should investors watch next?

Ans. Investors should watch whether the stock continues to trade near its 52-week high, whether the next session adds to the streak, and how the valuation compares with peers. The latest figures show the pattern, but not the reason behind it.

Track Innova Captab Ltd. (INNOVACAP) Share Price on Univest

Use Innova Captab Ltd. (INNOVACAP) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down